Compelling epidemiologic and molecular data indicate that genes play a primary role in
determining who is at risk for developing multiple sclerosis (MS), how the disease …

Multiple sclerosis (MS) progression to mortality may not be solely determined by the
underlying autoimmune process. We conducted a study in a large cohort of MS patients with …

Multiple sclerosis (MS) is an autoimmune disease that represents a primary cause of
neurological disability in the young adult population. Converging evidence supports the …

A province wide prevalence study on multiple sclerosis (MS) was conducted in British
Columbia (BC). The prevalence date was July 1, 1982. The major portion of this study was a …

[Epidemiology of multiple sclerosis in Spain]. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …

Previous reports on large population groups have suggested that the prevalence of multiple
sclerosis (MS) in Sicily and southern Italy is low, of the order of 4-8 per 100 000. In contrast …

Objective: To assess multiple sclerosis (MS) incidence from 1998 to 2007, and MS
prevalence on 31 December 2007, in the province of Genoa, Italy. Methods: We identified …

An epidemiological survey of multiple sclerosis (MS) in three Australian cities, Perth,
Newcastle and Hobart, was undertaken with its prevalence day being the national census …

In order to make a rough estimate of the number who have multiple sclerosis (MS) in the
world, it is first necessary to define what is meant by MS. The criteria which must be sat isfied …

Background The geographic distribution of multiple sclerosis (MS) is classically divided into
three zones based on frequency that were established by Kurtzke in the early 1970s. In …